about
Supportive therapies for prevention of hepatocellular carcinoma recurrence and preservation of liver functionTransition Metal Intercalators as Anticancer Agents-Recent AdvancesIron and cancer: more ore to be mined.Mechanistic characterization of a copper containing thiosemicarbazone with potent antitumor activity.Nucleotide metabolism, oncogene-induced senescence and cancer.Exploring the influence of the protein environment on metal-binding pharmacophores.Eryptosis as a marker of Parkinson's diseaseUpregulation of the host SLC11A1 gene by Clostridium difficile toxin B facilitates glucosylation of Rho GTPases and enhances toxin lethality.Transferrin-conjugated nanodiamond as an intracellular transporter of chemotherapeutic drug and targeting therapy for cancer cells.Pro-Oxidant Activity of Amine-Pyridine-Based Iron Complexes Efficiently Kills Cancer and Cancer Stem-Like CellsSynthesis, DNA Binding, and Antiproliferative Activity of Novel Acridine-Thiosemicarbazone DerivativesDeferasirox, a novel oral iron chelator, shows antiproliferative activity against pancreatic cancer in vitro and in vivo.Mechanistic studies of semicarbazone triapine targeting human ribonucleotide reductase in vitro and in mammalian cells: tyrosyl radical quenching not involving reactive oxygen species.Ectopic NGAL expression can alter sensitivity of breast cancer cells to EGFR, Bcl-2, CaM-K inhibitors and the plant natural product berberineEffects of ectopic expression of NGAL on doxorubicin sensitivity.Impact of Stepwise NH2-Methylation of Triapine on the Physicochemical Properties, Anticancer Activity, and Resistance CircumventionEffects of an oral iron chelator, deferasirox, on advanced hepatocellular carcinoma.Profound morphological changes in the erythrocytes and fibrin networks of patients with hemochromatosis or with hyperferritinemia, and their normalization by iron chelators and other agents.The iron chelator Dp44mT suppresses osteosarcoma's proliferation, invasion and migration: in vitro and in vivoEffects of Anti-repulsive Guidance Molecule C (RGMc/Hemojuvelin) Antibody on Hepcidin and Iron in Mouse Liver and Tumor XenograftsImaging PEG-like nanoprobes in tumor, transient ischemia, and inflammatory disease modelsRegulation of cellular iron metabolism and its implications in lung cancer progression.Iron Homeostasis and Trypanosoma brucei Associated Immunopathogenicity Development: A Battle/Quest for Iron.Two cell cycle blocks caused by iron chelation of neuroblastoma cells: separating cell cycle events associated with each block.Modulation of iron metabolism by iron chelation regulates intracellular calcium and increases sensitivity to doxorubicinThiosemicarbazones Functioning as Zinc Metallochaperones to Reactivate Mutant p53.The Iron Chelator, Dp44mT, Effectively Inhibits Human Oral Squamous Cell Carcinoma Cell Growth in Vitro and in Vivo.The potential of deferasirox as a novel therapeutic modality in gastric cancerEfficacy of iron chelator deferoxamine for hepatic arterial infusion chemotherapy in advanced hepatocellular carcinoma patients refractory to current treatments.Induction of apoptosis by Fe(salen)Cl through caspase-dependent pathway specifically in tumor cells.Iron depletion results in Src kinase inhibition with associated cell cycle arrest in neuroblastoma cells.BRAF mutations are associated with increased iron regulatory protein-2 expression in colorectal tumorigenesis.Deferasirox, an oral iron chelator, prevents hepatocarcinogenesis and adverse effects of sorafenib.Polycatechol Nanoparticle MRI Contrast Agents.Proteomic profiling reveals that collismycin A is an iron chelator.Novel α-substituted tropolones promote potent and selective caspase-dependent leukemia cell apoptosis.A novel method for assessing the role of iron and its functional chelation in fibrin fibril formation: the use of scanning electron microscopy.Expanding the Therapeutic Potential of the Iron Chelator Deferasirox in the Development of Aqueous Stable Ti(IV) Anticancer Complexes.Position paper on management of iron deficiency in adult cancer patients.The role of oxidative stress in activity of anticancer thiosemicarbazones.
P2860
Q28066295-52069118-1869-41D2-B144-712C378DF763Q28077365-AAF3161A-DE56-489B-99A5-61D1EE0960D3Q33677592-3785AE3A-312D-415B-A07A-61378C58208AQ33728282-0AB8B635-C41E-4C0D-BB2B-B2ED45342941Q33969333-082F8889-C902-4382-B8B5-B9A04EF7C7FCQ34104343-193C3C61-AEED-49DA-9DE6-426576FB9BF9Q34585744-0BFB48D3-9DF5-48E9-ACB9-46BF097792B9Q34729613-4FE840D7-5413-4EA5-BD0E-34E4237F616FQ35201951-013D6499-A188-4570-BAB4-F1834FCCA9C0Q35773665-61E874CD-38BA-4508-BF0E-1F84EF34EF58Q35813958-DD933B61-E6DB-41FE-95CF-FA2444BE9E2AQ36119319-44E25D41-DD31-4975-B75A-82AB3605E452Q36318799-CE1B28C6-9A63-4458-89FD-D62E4EC578B5Q36556350-2F2BAD19-23F0-4123-B859-FF9EF9EE6FB5Q37031268-74BFA53A-45AE-4C8E-A9F3-D47BB9867620Q37138681-8414009A-39B1-4078-AE0E-3FB8CB7D4BE3Q37373290-165AAFBF-BB5F-4D4B-B22A-2E360587BD87Q37458594-D0917418-4639-4817-892B-E1A4151D97ACQ37553760-B7023F36-57C3-4116-9467-08AA19D60BD8Q37638804-EB170DDF-5F23-4F29-ABF0-4D35AC15ECF1Q37735698-714C585C-3E1C-4D77-BD12-62A2D00EAB4AQ38214914-E1E3BF41-1DCB-48C2-84E2-E5D6378202D8Q38532068-054254B8-E8B5-465F-A8BA-7A760594CC55Q38568878-275E32D5-0E3F-4A96-89D9-88B2A7B2EE28Q38617735-77D618FF-D080-408B-A4E4-C8D920DF83F1Q38711481-E03C1EC3-42FF-4BA2-81D9-F95DEF73BFAFQ38748533-B2944AD0-E123-485F-97BA-C051E40D531CQ38787167-6651969E-78B2-459E-BEB9-228A13490393Q38982079-87C27F3A-57AD-4704-826C-2ACAFF5D9017Q38997514-DF9C037E-0403-4B88-B398-A599AF867010Q39508428-F93CA124-3692-487A-A18E-58660CFC8E7DQ41071955-CF064795-AB74-42CA-BD96-4994A560D7A9Q41494907-4AEA9742-B31E-4BF8-9A8F-A252A8644729Q41820535-9FC54008-D4F5-4FD8-A585-28B53B8722C5Q42358397-29C0D461-D180-4F4A-8693-A88A190F3F20Q42742732-594AAF68-74E8-4BA2-AD91-F8E0BA8451C2Q44286743-3E3B563A-DF93-4812-B469-B739601C758EQ46345511-1ACCC3D6-E17E-461A-8583-81ECEBD6682DQ48212676-EAF8ADC9-CB5B-4693-9874-1437B7A9BDBAQ52715779-04C33CA9-EA96-43AD-8727-AEDB5129CBBA
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Iron chelators for the treatment of cancer.
@en
Iron chelators for the treatment of cancer.
@nl
type
label
Iron chelators for the treatment of cancer.
@en
Iron chelators for the treatment of cancer.
@nl
prefLabel
Iron chelators for the treatment of cancer.
@en
Iron chelators for the treatment of cancer.
@nl
P2093
P1476
Iron chelators for the treatment of cancer
@en
P2093
D R Richardson
E Gutierrez
Y Suryo Rahmanto
Z Kovacevic
P304
P356
10.2174/092986712800609706
P50
P577
2012-01-01T00:00:00Z